Was #FunctionCreep von Innovation unterscheidet ist die qualitative Veränderung der Funktionsweise. Einer der möglichen Function Creeps für das #Covidzertifikat überschneidet sich mit der Agenda von mächtigen Interessensgruppen #Privacy#Datenschutz#digsec
Experten im Bereich #Überwachung und e-ID @whatsthatdata@Biometricstate erklären: «Smartphones sind jetzt Träger der Wahrheit im Kontext von Staatsbürgerschaft und Gesundheitsstatus, und werden nun auch zum Instrument für wirtschaftlichen Aufschwung und Anreiz» #Covidpass (2/)
#Covidzertifikate bergen ein erhebliches Risiko eines #FunctionCreep weil sie mit der Agenda von mächtigen Interessensgruppen im Einklang stehen. Seit 2020 haben private und staatliche Player die Einführung von #Covid19 Zertifikaten als Einfallstor für e-ID. (3/)
@EU_Commission@CharlesManoury erzählte uns: «Die Vorlage die den Mitgliedsstaaten zur Verfügung gestellt wurde um EU #Covid19 Zertifikate zu speichern ist das erste Modell aus dem eine vollständige #digitalwallet entstehen kann.» #CovidPass (4/)
Wir haben auch mit @HEaLInsti_FMES über #Aadhaar gesprochen, dem weltweit grössten biometrischen Identifikationssystem, welches mittlerweile mit allerhand Daten und Systemen verknüpft ist: «Ohne kannst du nicht mal mehr einen Pass kriegen». #biometrics#Überwachung#FunctionCreep
Meanwhile, in Switzerland @BAG_OFSP_UFSP claims #COVIDcertificate is stored only locally in the App on your smartphone: "Neither personal data nor the certificates are stored in a central system”. A leak and further research showed: it's more complicated than that #UVCI (3/)
Investigation by our @serenatinari on @BMJ_latest The @EMA_News Covid-19 vaccine leak show that some early commercial batches of Pfizer-BioNTech’s vaccine had lower than expected levels of intact mRNA, prompting wider questions about how to assess this novel vaccine platform 1/4
@EMA_news was victim of a cyberattack, the material delivered to journalists and academics. EMA was concerned about manufacturing not producing vaccines to the specifications expected, and unsure of the implications of low mRNA integrity on the vaccine safety and efficacy. 2/4
@BMJ_latest@serenatinari piece on mRNA integrity in Covid-19 vaccines raises questions about the lack of transparency. Companies and regulators said to the journal the specification limit acceptance criteria are commercially confidential @RecheckHealth 3/4
1/3 Just out: @RecheckHealth analysis and commentary Der seltsame Fall / le cas étrange / the Strange Case of the Swiss National COVID-19 Science Task Force @SwissScience_TF. Open access in Deutsch / Français / English. re-check.ch/wordpress/fr/s…
2/3 @SwissScience_TF is a group of scientists acting as a consultant to the Swiss authorities on #COVID19. Only his president should be talking to the media; is it really the case? And what are the rules of engagement of this very special board? @RecheckHealth
2/9 The article tracks back the approval history of the first vaccine to have been granted the FDA’s accelerated approval and fast track. @CatherineRiva and MD @gipispinosa combined published documents with DAPs and correspondence obtained with a #FOIA#Gardasil#HPV
3/9 The authors of @thejospi piece sought to understand how the evaluation criteria were selected during #Gardasil approval and the impact of the FDA experts’ choices on the quality of the available evidence about the vaccine’s efficacy. #Gardasil#HPV
1/
.@Doctors4Assange published in @TheLancet on behalf of 117 signatories hbs.ly/H02z580 “We are calling upon governments to end the torture of #Assange and ensure his access to the best available health care before it’s too late”
Care to kick off the New Year with a TWEETORIAL? Our humble homage to @VPrasadMDMPH will walk you through the evidence on #HPV vaccines and what @Cochranecollab made of it. Let’s first agree on one thing: RCTs are superior to observational studies
On HPV vaccines many observational studies published and hyped Randomized Controlled Trials on #Gardasil#Cervarix failed to demonstrate the expected efficacy though. It is sad, true and rarely discussed. Let’s have a closer look. @garyschwitzer@HealthNewsRevu@senseaboutsci
In 2006 @US_FDA VRBPAC Committee required @Merck to provide data and analyses on Gardasil RCTs FUTURE I and II.
Which outcome would you consider as the most relevant to assess Gardasil efficacy?